Literature DB >> 25359497

Lipid mediators in the resolution of inflammation.

Charles N Serhan1, Nan Chiang1, Jesmond Dalli1, Bruce D Levy2.   

Abstract

Mounting of the acute inflammatory response is crucial for host defense and pivotal to the development of chronic inflammation, fibrosis, or abscess formation versus the protective response and the need of the host tissues to return to homeostasis. Within self-limited acute inflammatory exudates, novel families of lipid mediators are identified, named resolvins (Rv), protectins, and maresins, which actively stimulate cardinal signs of resolution, namely, cessation of leukocytic infiltration, counterregulation of proinflammatory mediators, and the uptake of apoptotic neutrophils and cellular debris. The biosynthesis of these resolution-phase mediators in sensu stricto is initiated during lipid-mediator class switching, in which the classic initiators of acute inflammation, prostaglandins and leukotrienes (LTs), switch to produce specialized proresolving mediators (SPMs). In this work, we review recent evidence on the structure and functional roles of these novel lipid mediators of resolution. Together, these show that leukocyte trafficking and temporal spatial signals govern the resolution of self-limited inflammation and stimulate homeostasis.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25359497      PMCID: PMC4315926          DOI: 10.1101/cshperspect.a016311

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  138 in total

1.  Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production.

Authors:  Marion Man-Ying Chan; Andrea Rossi Moore
Journal:  J Immunol       Date:  2010-04-30       Impact factor: 5.422

2.  Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception.

Authors:  S Bang; S Yoo; T J Yang; H Cho; Y G Kim; S W Hwang
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

Review 3.  n-3 fatty acids in cardiovascular disease.

Authors:  Raffaele De Caterina
Journal:  N Engl J Med       Date:  2011-06-23       Impact factor: 91.245

4.  The effect of pioglitazone treatment on 15-epi-lipoxin A4 levels in patients with type 2 diabetes.

Authors:  Absalon D Gutierrez; Padma Sathyanarayana; Somasekhar Konduru; Yumei Ye; Yochai Birnbaum; Mandeep Bajaj
Journal:  Atherosclerosis       Date:  2012-05-07       Impact factor: 5.162

5.  Tonic inhibition of chemotaxis in human plasma.

Authors:  Stephen E Malawista; Anne de Boisfleury Chevance; Jo van Damme; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

6.  15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.

Authors:  Driss El Kebir; Levente József; Wanling Pan; Lili Wang; Nicos A Petasis; Charles N Serhan; János G Filep
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

7.  Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1.

Authors:  Gabrielle Fredman; Sungwhan F Oh; Srinivas Ayilavarapu; Hatice Hasturk; Charles N Serhan; Thomas E Van Dyke
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

8.  Infection regulates pro-resolving mediators that lower antibiotic requirements.

Authors:  Nan Chiang; Gabrielle Fredman; Fredrik Bäckhed; Sungwhan F Oh; Thad Vickery; Birgitta A Schmidt; Charles N Serhan
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

Review 9.  Role of basic science in the development of new medicines: examples from the eicosanoid field.

Authors:  Bengt Samuelsson
Journal:  J Biol Chem       Date:  2012-02-08       Impact factor: 5.157

10.  Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation.

Authors:  Antonio Recchiuti; Charles N Serhan
Journal:  Front Immunol       Date:  2012-10-22       Impact factor: 7.561

View more
  153 in total

1.  Resolvin D1, resolvin D2 and maresin 1 activate the GSK3β anti-inflammatory axis in TLR4-engaged human monocytes.

Authors:  Zhen Gu; Gwyneth J Lamont; Richard J Lamont; Silvia M Uriarte; Huizhi Wang; David A Scott
Journal:  Innate Immun       Date:  2016-02-15       Impact factor: 2.680

Review 2.  Advances in Biomaterials for Drug Delivery.

Authors:  Owen S Fenton; Katy N Olafson; Padmini S Pillai; Michael J Mitchell; Robert Langer
Journal:  Adv Mater       Date:  2018-05-07       Impact factor: 30.849

Review 3.  Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids.

Authors:  Milan Fiala; Gijs Kooij; Karen Wagner; Bruce Hammock; Matteo Pellegrini
Journal:  FASEB J       Date:  2017-04-18       Impact factor: 5.191

Review 4.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

5.  The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect.

Authors:  Victor Fattori; Felipe A Pinho-Ribeiro; Larissa Staurengo-Ferrari; Sergio M Borghi; Ana C Rossaneis; Rubia Casagrande; Waldiceu A Verri
Journal:  Br J Pharmacol       Date:  2019-04-15       Impact factor: 8.739

6.  Resolvin D1 inhibits the proliferation of lipopolysaccharide-treated HepG2 hepatoblastoma and PLC/PRF/5 hepatocellular carcinoma cells by targeting the MAPK pathway.

Authors:  You Lu; Qingyu Xu; Guowen Yin; Weidong Xu; Hao Jiang
Journal:  Exp Ther Med       Date:  2018-08-23       Impact factor: 2.447

Review 7.  Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.

Authors:  Melis Çolakoğlu; Sinem Tunçer; Sreeparna Banerjee
Journal:  Cell Prolif       Date:  2018-07-30       Impact factor: 6.831

Review 8.  Prostaglandin E2 as a Regulator of Immunity to Pathogens.

Authors:  Giovanny J Martínez-Colón; Bethany B Moore
Journal:  Pharmacol Ther       Date:  2017-12-22       Impact factor: 12.310

Review 9.  Advanced Age Alters Monocyte and Macrophage Responses.

Authors:  Joslyn M Albright; Robert C Dunn; Jill A Shults; Devin M Boe; Majid Afshar; Elizabeth J Kovacs
Journal:  Antioxid Redox Signal       Date:  2016-08-03       Impact factor: 8.401

Review 10.  Can Specialized Pro-resolving Mediators Deliver Benefit Originally Expected from Fish Oil?

Authors:  Martin D Rosenthal; Jayshil Patel; Kyle Staton; Robert G Martindale; Frederick A Moore; Gilbert R Upchurch
Journal:  Curr Gastroenterol Rep       Date:  2018-08-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.